SCOLR Ships Product to Europe

SCOLR Ships Product to Europe

REDMOND, Wash.--SCOLR shipped its patented CDTglucosamine/chondroitin to its first-to-market European customer, SpringfieldNutraceuticals, to roll out in May. Springfield Nutraceuticals, based inOud-Beijerland, The Netherlands, plans to expand distribution of the productinto Southern Europe by the end of 2003.

"This first European commercialization of our patented CDTtechnology will help to generate early revenue streams from dietary supplementproducts, which will provide some support for the longer term investmentsnecessary to bring a prescription drug utilizing CDT to market after 2003,"said David Howard, president of SCOLR (dba Nutraceutix Inc., www.nutraceutix.com).